Home › Trial NCT02760225
Pembrolizumab-PET Imaging
- Trial IDNCT02760225
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorUniversity Medical Center Groningen
- Enrollment18
- Start date2016-10-24
- ConditionsMelanoma · Non-small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.